Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Workday
WDAY
|
$415M |
| 2 |
Atlassian
TEAM
|
$397M |
| 3 |
TJX Companies
TJX
|
$266M |
| 4 |
Corteva
CTVA
|
$199M |
| 5 |
JPMorgan Chase
JPM
|
$163M |
Top Sells
| 1 |
Apple
AAPL
|
$2.44B |
| 2 |
Microsoft
MSFT
|
$1.41B |
| 3 |
Amazon
AMZN
|
$657M |
| 4 |
Alphabet (Google) Class C
GOOG
|
$564M |
| 5 |
Meta Platforms (Facebook)
META
|
$537M |
Sector Composition
| 1 | Technology | 30.37% |
| 2 | Healthcare | 21.1% |
| 3 | Financials | 10.49% |
| 4 | Consumer Discretionary | 10.11% |
| 5 | Industrials | 9.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AGEN
2526
Agenus
AGEN
$138M
| $65K | ﹤0.01% |
1,698
+4
| +0.2% | +$153 |
|
2527
Amneal Pharmaceuticals
AMRX
$3.02B
| $63K | ﹤0.01% |
19,775
+49
| +0.2% | +$156 |
|
2528
Butterfly Network
BFLY
$393M
| $63K | ﹤0.01% |
20,484
+92
| +0.5% | +$283 |
|
|
BTRS
2529
DELISTED
BTRS Holdings Inc. Class 1 Common Stock
BTRS
| $63K | ﹤0.01% |
12,690
+316
| +3% | +$1.57K |
|
2530
Angi Inc
ANGI
$811M
| $62K | ﹤0.01% |
1,355
+4
| +0.3% | +$183 |
|
2531
Hyliion Holdings
HYLN
$309M
| $62K | ﹤0.01% |
19,456
+242
| +1% | +$771 |
|
2532
Cricut
CRCT
$1.26B
| $61K | ﹤0.01% |
+10,015
| New | +$61K |
|
2533
Cantaloupe
CTLP
$792M
| $61K | ﹤0.01% |
10,911
+52
| +0.5% | +$291 |
|
2534
MaxCyte
MXCT
$150M
| $61K | ﹤0.01% |
13,000
| – | – |
|
|
AMRS
2535
DELISTED
Amyris Inc.
AMRS
| $61K | ﹤0.01% |
32,418
+670
| +2% | +$1.26K |
|
2536
Hippo Holdings
HIPO
$832M
| $60K | ﹤0.01% |
2,739
+53
| +2% | +$1.16K |
|
2537
Stitch Fix
SFIX
$737M
| $60K | ﹤0.01% |
12,251
-8
| -0.1% | -$39 |
|
|
EGIO
2538
DELISTED
Edgio, Inc. Common Stock
EGIO
| $59K | ﹤0.01% |
631
| – | – |
|
2539
Ribbon Communications
RBBN
$707M
| $57K | ﹤0.01% |
18,595
-439
| -2% | -$1.35K |
|
2540
Workhorse Group
WKHS
$19.4M
| $57K | ﹤0.01% |
89
| – | – |
|
2541
Oscar Health
OSCR
$5.02B
| $56K | ﹤0.01% |
13,242
+290
| +2% | +$1.23K |
|
2542
Karyopharm Therapeutics
KPTI
$57.2M
| $55K | ﹤0.01% |
815
+4
| +0.5% | +$270 |
|
2543
Mersana Therapeutics
MRSN
$34M
| $53K | ﹤0.01% |
454
+6
| +1% | +$700 |
|
2544
Alto Ingredients
ALTO
$90.6M
| $52K | ﹤0.01% |
13,956
-2
| -0% | -$7 |
|
|
PLG
2545
Platinum Group Metals
PLG
$186M
| $52K | ﹤0.01% |
40,165
-152,521
| -79% | -$197K |
|
2546
Quantum-Si Incorporated
QSI
$219M
| $52K | ﹤0.01% |
22,206
+239
| +1% | +$560 |
|
|
HYZN
2547
DELISTED
Hyzon Motors Inc. Class A Common Stock
HYZN
| $52K | ﹤0.01% |
358
+20
| +6% | +$2.91K |
|
|
IDEX
2548
DELISTED
Ideanomics, Inc. Common Stock
IDEX
| $52K | ﹤0.01% |
618
+1
| +0.2% | +$84 |
|
2549
MiMedx Group
MDXG
$1.06B
| $51K | ﹤0.01% |
14,897
+183
| +1% | +$627 |
|
2550
Heron Therapeutics
HRTX
$201M
| $50K | ﹤0.01% |
17,691
-39
| -0.2% | -$110 |
|